Donald G. Payan
2014
In 2014, Donald G. Payan earned a total compensation of $1.4M as Executive Vice President, of Discovery and Research at Rigel Pharmaceuticals, a 7% decrease compared to previous year.
Compensation breakdown
| Option Awards | $784,290 |
|---|---|
| Salary | $559,571 |
| Other | $9,906 |
| Total | $1,353,767 |
Payan received $784.3K in option awards, accounting for 58% of the total pay in 2014.
Payan also received $559.6K in salary and $9.9K in other compensation.
Rankings
In 2014, Donald G. Payan's compensation ranked 6,241st out of 13,032 executives tracked by ExecPay. In other words, Payan earned more than 52.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,241 out of 13,032 | 52nd |
Division Manufacturing | 2,271 out of 4,965 | 54th |
Major group Chemicals And Allied Products | 758 out of 1,690 | 55th |
Industry group Drugs | 591 out of 1,369 | 57th |
Industry Pharmaceutical Preparations | 451 out of 1,042 | 57th |
Source: SEC filing on March 28, 2016.
Payan's colleagues
We found five more compensation records of executives who worked with Donald G. Payan at Rigel Pharmaceuticals in 2014.
2014
James Gower
Rigel Pharmaceuticals
Chief Executive Officer
2014
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
2014
Elliott Grossbard
Rigel Pharmaceuticals
Chief Medical Officer
2014
Dolly Vance
Rigel Pharmaceuticals
General Counsel
2014
Ryan Maynard
Rigel Pharmaceuticals